Alaa Alghamry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alaa Alghamry has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Joseph C. Lee
Department of Medical Imaging, The Prince Charles Hospital, Chermside, QLD 4032, Australia; Faculty of Medicine, University of Queensland, Herston, Australia
8 shared publications Jia Wen Chong
Faculty of Medicine, University of Queensland, Herston Rd, Herston, 4006, Australia (J.C.L., J.W.C., A.A., P.J.M.).
3 shared publicationsAditya Agarwal
Department of Gastroenterology and Hepatology, Centre for Service and Quality Improvement, The Prince Charles Hospital, Chermside, Queensland, Australia
1 shared publicationAnita Pelecanos
QIMR Berghofer Medical Research Institute, Brisbane, Australia
1 shared publicationAnn E Vandeleur
Department of Gastroenterology and Hepatology, Centre for Service and Quality Improvement, The Prince Charles Hospital, Chermside, Queensland, Australia
1 shared publicationCassie Oxenford
Department of Medicine, Redcliffe Hospital, Redcliffe, Australia
1 shared publication
Latest Publications
- 28 May 2025
- Published by Elsevier in Academic Radiology
Ventilation-Perfusion Imaging, Pendulums, and the Scales of Justice
- 28 May 2025
- Published by Elsevier in Academic Radiology
Ventilation-Perfusion Imaging, Pendulums, and the Scales of Justice
- 21 March 2024
- Published by Elsevier in Academic Radiology
- Vol. 31 (6) , 2640
Under-utilization of V/Q-SPECT
- 21 March 2024
- Published by Elsevier in Academic Radiology
- Vol. 31 (6) , 2640
Under-utilization of V/Q-SPECT
- 28 June 2023
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 116 (8-9) , 426
Cardiovascular events in the context of coronavirus disease 2019: Letter in response to “Two-year prognosis of acute coronary syndrome during the first wave of the coronavirus disease 2019 pandemic” by Gabrion et al.
- 28 June 2023
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 116 (8-9) , 426
Cardiovascular events in the context of coronavirus disease 2019: Letter in response to “Two-year prognosis of acute coronary syndrome during the first wave of the coronavirus disease 2019 pandemic” by Gabrion et al.
- Open Access
- 29 September 2022
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 8 (3) , 131
Significant change for body composition data
- 29 September 2022
- Published by Elsevier in Osteoporosis and Sarcopenia
- Vol. 8 (3) , 131
Open AccessSignificant change for body composition data
- Top Cited Papers
- 1 August 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (8) , 2538-2548
Long-Term Survival, Stroke Recurrence, and Life Expectancy After an Acute Stroke in Australia and New Zealand From 2008–2017: A Population-Wide Cohort Study
Background: Data on long-term outcomes following an acute stroke are sparse. We assessed survival, risk of recurrent stroke and loss in life expectancy following an acute stroke using population-wide data from Australia and New Zealand. Methods: We included all adults with the first stroke hospitalization during 2008 and 2017 at all public and most private hospitals. Patients were followed up to 10 years after the stroke by linkage to each region’s Registry of Deaths and subsequent hospitalizations. Flexible parametric survival modeling was used to estimate all-cause mortality, stroke recurrence, and loss in life expectancy. Competing risk model was used when estimating the risk of stroke recurrence. Results: Three hundred thirteen thousand one hundred sixty-two patients were included (mean age 73.0±14.6 y, 52.0% males) with ischemic stroke (175 547, 56.1%) being the most common, followed by hemorrhagic stroke (77 940, 24.9%) and unspecified stroke (59 675, 19.1%). The overall survival probability was 79.4% at 3 months, 73.0% at 1 year, 52.8% at 5 years, and 36.4% at 10 years. Cumulative incidence of stroke recurrence was 7.8% at 3 months, 11.0% at 1 year, 19.8% at 5 years, and 26.8% at 10 years. Hemorrhagic stroke was associated with greater mortality (hazard ratio, 2.02 [95% CI, 1.99–2.04]) and recurrent stroke (hazard ratio, 1.63 [95% CI, 1.59–1.67]) compared with ischemic stroke. Female sex (hazard ratio, 1.10 [95% CI, 1.09–1.11]) and increasing age (≥85 years versus 18–54 years: hazard ratio, 7.36 [95% CI, 7.15–7.57]) were also associated with increased mortality. Several risk factors including atherosclerotic coronary and noncoronary vascular disease, cardiac arrhythmia, and diabetes were associated with increased risk of mortality and recurrent stroke. Compared with the general population, an acute stroke was associated with a loss of 5.5 years of life expectancy, or 32.7% of the predicted life expectancy, and was pronounced in patients with a hemorrhagic stroke (7.4 years and 38.5% of predicted life expectancy lost). Conclusions: In this population-wide study, death and recurrence of stroke were common after an acute stroke and an acute stroke was associated with considerable loss in life expectancy. Further improvements in treatment and secondary prevention of stroke are needed to reduce these risks.
- 1 August 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (8) , 2538-2548
Top Cited PapersLong-Term Survival, Stroke Recurrence, and Life Expectancy After an Acute Stroke in Australia and New Zealand From 2008–2017: A Population-Wide Cohort Study
Background: Data on long-term outcomes following an acute stroke are sparse. We assessed survival, risk of recurrent stroke and loss in life expectancy following an acute stroke using population-wide data from Australia and New Zealand. Methods: We included all adults with the first stroke hospitalization during 2008 and 2017 at all public and most private hospitals. Patients were followed up to 10 years after the stroke by linkage to each region’s Registry of Deaths and subsequent hospitalizations. Flexible parametric survival modeling was used to estimate all-cause mortality, stroke recurrence, and loss in life expectancy. Competing risk model was used when estimating the risk of stroke recurrence. Results: Three hundred thirteen thousand one hundred sixty-two patients were included (mean age 73.0±14.6 y, 52.0% males) with ischemic stroke (175 547, 56.1%) being the most common, followed by hemorrhagic stroke (77 940, 24.9%) and unspecified stroke (59 675, 19.1%). The overall survival probability was 79.4% at 3 months, 73.0% at 1 year, 52.8% at 5 years, and 36.4% at 10 years. Cumulative incidence of stroke recurrence was 7.8% at 3 months, 11.0% at 1 year, 19.8% at 5 years, and 26.8% at 10 years. Hemorrhagic stroke was associated with greater mortality (hazard ratio, 2.02 [95% CI, 1.99–2.04]) and recurrent stroke (hazard ratio, 1.63 [95% CI, 1.59–1.67]) compared with ischemic stroke. Female sex (hazard ratio, 1.10 [95% CI, 1.09–1.11]) and increasing age (≥85 years versus 18–54 years: hazard ratio, 7.36 [95% CI, 7.15–7.57]) were also associated with increased mortality. Several risk factors including atherosclerotic coronary and noncoronary vascular disease, cardiac arrhythmia, and diabetes were associated with increased risk of mortality and recurrent stroke. Compared with the general population, an acute stroke was associated with a loss of 5.5 years of life expectancy, or 32.7% of the predicted life expectancy, and was pronounced in patients with a hemorrhagic stroke (7.4 years and 38.5% of predicted life expectancy lost). Conclusions: In this population-wide study, death and recurrence of stroke were common after an acute stroke and an acute stroke was associated with considerable loss in life expectancy. Further improvements in treatment and secondary prevention of stroke are needed to reduce these risks.
- 5 May 2022
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 54 (3) , 500-501
Contemporary use of ventilation-perfusion imaging for pulmonary embolism diagnosis
- 5 May 2022
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 54 (3) , 500-501
Contemporary use of ventilation-perfusion imaging for pulmonary embolism diagnosis
- 4 June 2020
- Published by Springer Nature in Journal of Echocardiography
- Vol. 18 (4) , 265-266
Leadership to improve consistency in echocardiography data
- 4 June 2020
- Published by Springer Nature in Journal of Echocardiography
- Vol. 18 (4) , 265-266
Leadership to improve consistency in echocardiography data
- 1 March 2017
- Published by Wiley in Journal of Digestive Diseases
- Vol. 18 (3) , 160-168
Split‐dose bowel preparation with polyethylene glycol for colonoscopy performed under propofol sedation. Is there an optimal timing?
OBJECTIVE: Aspiration risk, especially with propofol sedation, remains a concern after split‐dose bowel preparation of up to 1 L polyethylene glycol for the procedure. We aimed to identify the ideal timing of bowel preparation to achieve optimal colon cleansing with no increased risk of aspiration.METHODS: A total of 892 consecutive patients undergoing simultaneous esophagogastroduodenoscopy (EGD) and colonoscopy were prospectively recruited. Residual gastric volume (RGV) and pH of gastric contents were measured at EGD, and patients' characteristics, runway time (duration between completion of the final liter of bowel preparation and colonoscopy commencement), and cleansing quality were recorded.RESULTS: A shorter runway time resulted in better colon cleansing (r = −0.124, P < 0.001). No correlation between runway time and RGV or pH was found (r = −0.017, P = 0.62 and r = −0.030, P = 0.47, respectively). RGV and pH did not differ significantly with runway time of 4 or 5 h. RGV with runway time ≤3 h was 35.9 ± 11.8 mL and 17.4 ± 0.6 mL after runway time >3 h (P < 0.001). No aspiration pneumonia occurred. The only factors independently related to higher RGV were younger age and male sex.CONCLUSIONS: The consumption of bowel preparation agent within 3–4 h before propofol sedation resulted in a similar RGV and pH as those achieved by more prolonged fasting, with no increased risk of aspiration even in patients perceived to be at high risk.
- 1 March 2017
- Published by Wiley in Journal of Digestive Diseases
- Vol. 18 (3) , 160-168
Split‐dose bowel preparation with polyethylene glycol for colonoscopy performed under propofol sedation. Is there an optimal timing?
OBJECTIVE: Aspiration risk, especially with propofol sedation, remains a concern after split‐dose bowel preparation of up to 1 L polyethylene glycol for the procedure. We aimed to identify the ideal timing of bowel preparation to achieve optimal colon cleansing with no increased risk of aspiration.METHODS: A total of 892 consecutive patients undergoing simultaneous esophagogastroduodenoscopy (EGD) and colonoscopy were prospectively recruited. Residual gastric volume (RGV) and pH of gastric contents were measured at EGD, and patients' characteristics, runway time (duration between completion of the final liter of bowel preparation and colonoscopy commencement), and cleansing quality were recorded.RESULTS: A shorter runway time resulted in better colon cleansing (r = −0.124, P < 0.001). No correlation between runway time and RGV or pH was found (r = −0.017, P = 0.62 and r = −0.030, P = 0.47, respectively). RGV and pH did not differ significantly with runway time of 4 or 5 h. RGV with runway time ≤3 h was 35.9 ± 11.8 mL and 17.4 ± 0.6 mL after runway time >3 h (P < 0.001). No aspiration pneumonia occurred. The only factors independently related to higher RGV were younger age and male sex.CONCLUSIONS: The consumption of bowel preparation agent within 3–4 h before propofol sedation resulted in a similar RGV and pH as those achieved by more prolonged fasting, with no increased risk of aspiration even in patients perceived to be at high risk.